Lithium carbonate therapy for zidovudine-associated neutropenia in patients with acquired immunodeficiency syndrome.
Klutman
N E
NE
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000380:Agranulocytosis / Q000188:drug therapy*; D006801:Humans; D008094:Lithium / Q000097:blood / Q000627:therapeutic use*; D016651:Lithium Carbonate; D008991:Monitoring, Physiologic; D009503:Neutropenia / Q000139:chemically induced / Q000188:drug therapy*; D015215:Zidovudine / Q000009:adverse effects*
D016651:Lithium Carbonate; D015215:Zidovudine; D008094:Lithium